Eurofins Scientific SE (XSWX:ERF) Accounts Payable & Accrued Expense : CHF1,232 Mil (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Eurofins Scientific SE Accounts Payable & Accrued Expense?

Eurofins Scientific SE's quarterly accounts payable & accrued expense declined from Dec. 2022 (CHF1,322 Mil) to Jun. 2023 (CHF686 Mil) but then increased from Jun. 2023 (CHF686 Mil) to Dec. 2023 (CHF1,232 Mil).

Eurofins Scientific SE's annual accounts payable & accrued expense declined from Dec. 2021 (CHF1,467 Mil) to Dec. 2022 (CHF1,322 Mil) and declined from Dec. 2022 (CHF1,322 Mil) to Dec. 2023 (CHF1,232 Mil).

Eurofins Scientific SE Accounts Payable & Accrued Expense Historical Data

The historical data trend for Eurofins Scientific SE's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins Scientific SE Accounts Payable & Accrued Expense Chart

Eurofins Scientific SE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1,079.11

1,389.67

1,467.04

1,322.20

1,232.03

Eurofins Scientific SE Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1,467.04	723.04	1,322.20	685.59	1,232.03

Eurofins Scientific SE Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Eurofins Scientific SE (XSWX:ERF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins Scientific SE (XSWX:ERF) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ERFSF:USA ERFp:UK 0MV5:UK ERF:France ESF0:Germany

Address

23 Val Fleuri, Luxembourg, LUX, L-1526

Website

https://www.eurofins.com

Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its main business activities are food and environmental testing, biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.